These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 14754799)
1. On biology, phenomenology, and pharmacology in schizophrenia. Freudenreich O Am J Psychiatry; 2004 Feb; 161(2):376; author reply 377-8. PubMed ID: 14754799 [No Abstract] [Full Text] [Related]
2. Dopamine release in the nucleus accumbens: the perspective from aberrations of consciousness in schizophrenia. Gray JA Neuropsychologia; 1995 Sep; 33(9):1143-53. PubMed ID: 7501135 [TBL] [Abstract][Full Text] [Related]
3. On biology, phenomenology, and pharmacology in schizophrenia. Jones HM Am J Psychiatry; 2004 Feb; 161(2):376-7; author reply 377-8. PubMed ID: 14754797 [No Abstract] [Full Text] [Related]
4. On biology, phenomenology, and pharmacology in schizophrenia. Gray JA Am J Psychiatry; 2004 Feb; 161(2):377; author reply 377-8. PubMed ID: 14754801 [No Abstract] [Full Text] [Related]
5. On biology, phenomenology, and pharmacology in schizophrenia. Crane DL Am J Psychiatry; 2004 Feb; 161(2):376; author reply 377-8. PubMed ID: 14754798 [No Abstract] [Full Text] [Related]
6. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. Stahl SM CNS Spectr; 2007 Apr; 12(4):265-8. PubMed ID: 17426663 [No Abstract] [Full Text] [Related]
7. Dopamine, the prefrontal cortex and schizophrenia. Knable MB; Weinberger DR J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376 [TBL] [Abstract][Full Text] [Related]
8. [Dreaming and schizophrenia: a common neurobiological background?]. Gottesmann C Med Sci (Paris); 2006 Feb; 22(2):201-5. PubMed ID: 16457764 [TBL] [Abstract][Full Text] [Related]
10. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Gray JA; Joseph MH; Hemsley DR; Young AM; Warburton EC; Boulenguez P; Grigoryan GA; Peters SL; Rawlins JN; Taib CT Behav Brain Res; 1995 Nov; 71(1-2):19-31. PubMed ID: 8747172 [TBL] [Abstract][Full Text] [Related]
11. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Kapur S Am J Psychiatry; 2003 Jan; 160(1):13-23. PubMed ID: 12505794 [TBL] [Abstract][Full Text] [Related]
13. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else? Benes FM Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640 [No Abstract] [Full Text] [Related]
14. Left striato-pallidal hyperactivity in schizophrenia. Part II: Phenomenology and thought disorder. Early TS; Posner MI; Reiman EM; Raichle ME Psychiatr Dev; 1989; 7(2):109-21. PubMed ID: 2695922 [TBL] [Abstract][Full Text] [Related]
18. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. O'Donnell P; Grace AA Schizophr Bull; 1998; 24(2):267-83. PubMed ID: 9613625 [TBL] [Abstract][Full Text] [Related]
19. The interface between dopamine neurons and the amygdala: implications for schizophrenia. Haber SN; Fudge JL Schizophr Bull; 1997; 23(3):471-82. PubMed ID: 9327510 [TBL] [Abstract][Full Text] [Related]
20. Connecting the "dots" of brain dysfunction in schizophrenia: what does the picture look like? Braff DL Arch Gen Psychiatry; 1999 Sep; 56(9):791-3. PubMed ID: 12884884 [No Abstract] [Full Text] [Related] [Next] [New Search]